Title: Oligonucleotide Compositions with Enhanced Efficacy. Number: 20040054155. Filed: Oct. 2, 2003. Lead Inventor: Tod Woolf, Sequitur (Invitrogen).
The patent application, its abstract states, covers “oligonucleotide compositions [that] … make use of combinations of oligonucleotides. In one aspect, the invention features an oligonucleotide composition including at least two different oligonucleotides targeted to a target gene.”
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
